The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy
|
---|---|
Published in |
Frontiers in oncology, December 2021
|
DOI | 10.3389/fonc.2021.789078 |
Pubmed ID | |
Authors |
Hoyoung M. Maeng, Brittni N. Moore, Hadi Bagheri, Seth M. Steinberg, Jon Inglefield, Kim Dunham, Wei-Zen Wei, John C. Morris, Masaki Terabe, Lee C. England, Brenda Roberson, Douglas Rosing, Vandana Sachdev, Svetlana D. Pack, Markku M. Miettinen, Frederic G. Barr, Louis M. Weiner, Sandhya Panch, David F. Stroncek, Lauren V. Wood, Jay A. Berzofsky |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 22% |
Unknown | 7 | 78% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Scientists | 3 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 18 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 22% |
Unspecified | 2 | 11% |
Lecturer | 2 | 11% |
Professor > Associate Professor | 1 | 6% |
Student > Postgraduate | 1 | 6% |
Other | 0 | 0% |
Unknown | 8 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 2 | 11% |
Immunology and Microbiology | 2 | 11% |
Medicine and Dentistry | 2 | 11% |
Agricultural and Biological Sciences | 1 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Other | 2 | 11% |
Unknown | 8 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2021.
All research outputs
#7,205,479
of 26,329,145 outputs
Outputs from Frontiers in oncology
#2,402
of 22,974 outputs
Outputs of similar age
#149,703
of 528,231 outputs
Outputs of similar age from Frontiers in oncology
#118
of 1,354 outputs
Altmetric has tracked 26,329,145 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 22,974 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 528,231 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 1,354 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.